AAEP Encouraged Revision of Sedative Rule
An experienced equine veterinarian drawing on more than three decades of experience in treating lameness in standardbred and other performance horses, Dr. Phillip Kapraun is the owner of Harvard Equine Practice in Harvard, Illinois. To keep up with developments in equine medicine, Dr. Phillip Kapraun maintains membership with professional organizations such as the American Veterinary Medical Association and the American Association of Equine Practitioners (AAEP).
In September 2022, the American Association of Equine Practitioners (AAEP) sent a letter to the National Horse Reining Association, recommending a revisit of a contemporary policy that allowed the use of compounded romifidine as a sedative for racing horses. The policy of the National Horse Reining Association asserts that compounded romifidine can be administered 30 minutes before competition.
The caveats in the letter concerning the drug revised potential negative effects of the compounded romifidine, which are backed by multiple studies.n area of concern is that the sedative effect of compounded romifidine sometimes takes longer than 30 minutes.
Entering competition 30-minutes post administration can give a horse a head start compared to its fellow equine contenders because of its temporary immunity to painful stimuli, enhancing its performance. This is not a fair practice. Studies have found that moderate sedation from compounded romifidine (about 30 minutes post-administration) may continue for up to two hours.
The temporary immunity to painful stimuli can also mask lameness in the competition since the horse won't feel it. This can result in extensive damage to the limbs while racing. The rider's safety is also threatened since the horse may eventually trip from severe injury during the competition.













